Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rabab M. A. Mahmoud"'
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 28, Iss 3, Pp 116-122 (2016)
Background Worldwide, the population treated with renal replacement therapy is increasing, representing ∼1.3 million patients who undergo dialysis and 400 000 patients who are alive with a kidney transplant. Transplantation is more predictable than
Publikováno v:
The Egyptian Journal of Internal Medicine, Vol 28, Iss 4, Pp 162-169 (2016)
Background Many factors and events can complicate the outcome of renal transplantation and can eventually lead to progressive renal dysfunction and graft failure. We aimed in this study to identify the risk factors for the entire course after transpl
Autor:
Rabab M. A. Mahmoud, Amr Mohammed Shaker, Khaled Marzouk Sadek, May Hassaballa, Mervat Mohammed El-Ansari, Mohammed Saadi, Tarek Fayad
Publikováno v:
Journal of The Egyptian Society of Nephrology and Transplantation. 16:119
Aim Phospholipase A2 receptor (PLA2R) in the past few years has been identified as an antigenic target in idiopathic membranous nephropathy (IMN). The question remains, however, whether the diagnostic and prognostic values of anti-phospholipase A2 re
Autor:
Rabab M. A. Mahmoud, Ann Ali, Mohamed Momtaz, Bahaa Zayed, Amr M. Shaker, Mohamed G. Saadi, Khaled Marzouk
Publikováno v:
Journal of The Egyptian Society of Nephrology and Transplantation. 16:79
Background β 2 -Microglobulin (β 2 -MG) is a uremic toxin that is retained in patients with end-stage renal disease. Interleukin-6 (IL-6) besides being an inflammatory marker has emerged as an independent predictor of mortality in end-stage renal d